<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nefr</journal-id><journal-title-group><journal-title xml:lang="ru">Нефрология</journal-title><trans-title-group xml:lang="en"><trans-title>Nephrology (Saint-Petersburg)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1561-6274</issn><issn pub-type="epub">2541-9439</issn><publisher><publisher-name>Pavlov First Saint-Petersburg State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">nefr-182</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ. ЭКСПЕРИМЕНТАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES. EXPERIMENTAL INVESTIGATION</subject></subj-group></article-categories><title-group><article-title>Влияние ингибиторов ангиотензин-превращающего фермента на уровень профиброгенных факторов роста в моче и морфологические изменения в паренхиме почек у крыс с инфицированным пузырно-мочеточниковым рефлюксом</article-title><trans-title-group xml:lang="en"><trans-title>The effect of angiotensin-converting enzyme inhibitors on urine level of profibrogenic growth factors and morphological changes in the renal parenchyma in rats with infected vesicoureteral reflux</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зайкова</surname><given-names>Наталья М.</given-names></name><name name-style="western" xml:lang="en"><surname>Zaicova</surname><given-names>N. M.</given-names></name></name-alternatives><email xlink:type="simple">nataliazaikova@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Длин</surname><given-names>Владимир Викторович</given-names></name><name name-style="western" xml:lang="en"><surname>Dlin</surname><given-names>Vladimir V.</given-names></name></name-alternatives><email xlink:type="simple">niki@pedklin.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Петрович</surname><given-names>Вержил Георгевич</given-names></name><name name-style="western" xml:lang="en"><surname>Petrovici</surname><given-names>Verjil G.</given-names></name></name-alternatives><email xlink:type="simple">petrovicivergil@yahoo.com</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Синицына</surname><given-names>Лилия Васильевна</given-names></name><name name-style="western" xml:lang="en"><surname>Sinitcina</surname><given-names>Lilia V</given-names></name></name-alternatives><email xlink:type="simple">liliasinitsina@mail.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Корсунский</surname><given-names>Анатолий Александрович</given-names></name><name name-style="western" xml:lang="en"><surname>Korsunschii</surname><given-names>Anatolii A.</given-names></name></name-alternatives><email xlink:type="simple">dr_kaa@mail.ru</email><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гацкан</surname><given-names>Штефан Георгиевич</given-names></name><name name-style="western" xml:lang="en"><surname>Gatckan</surname><given-names>Stefan G.</given-names></name></name-alternatives><email xlink:type="simple">stgatkan@mail.ru</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">Институт Матери и Ребенка; Первый Московский государственный медицинский университет им. И.М. Сеченова<country>Россия</country></aff><aff xml:lang="en">Institution of Mother and Child Care; I.M. Sechenov First Moscow State Medical University<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru">Научно-исследовательский клинический институт педиатрии Российского научноисследовательского медицинского университета им. Н.И. Пирогова<country>Россия</country></aff><aff xml:lang="en">Pirogov Russian National Research Medical University<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru">Институт Матери и Ребенка<country>Россия</country></aff><aff xml:lang="en">Institution of Mother and Child Care<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru">Первый Московский государственный медицинский университет им. И.М. Сеченова<country>Россия</country></aff><aff xml:lang="en">I.M. Sechenov First Moscow State Medical University<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2016</year></pub-date><pub-date pub-type="epub"><day>01</day><month>05</month><year>2016</year></pub-date><volume>20</volume><issue>3</issue><fpage>85</fpage><lpage>95</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Зайкова Н.М., Длин В.В., Петрович В.Г., Синицына Л.В., Корсунский А.А., Гацкан Ш.Г., 2016</copyright-statement><copyright-year>2016</copyright-year><copyright-holder xml:lang="ru">Зайкова Н.М., Длин В.В., Петрович В.Г., Синицына Л.В., Корсунский А.А., Гацкан Ш.Г.</copyright-holder><copyright-holder xml:lang="en">Zaicova N.M., Dlin V.V., Petrovici V.G., Sinitcina L.V., Korsunschii A.A., Gatckan S.G.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.nephrolog.ru/jour/article/view/182">https://journal.nephrolog.ru/jour/article/view/182</self-uri><abstract><p>При экспериментальном инфицированном пузырно-мочеточниковом рефлюксе у крыс были установлены различные неоднотипные структурно-анатомические изменения со стороны почечно-мочеточникового комплекса на 1-, 3- и 6-м месяце эксперимента. Выраженность морфофункциональных изменений паренхимы почек взаимосвязана со степенью тяжести ПМР и длительностью воспалительного процесса в почечной ткани, что и определяет развитие тубулоинтерсти-циального фиброза. Высокий мочевой уровень Ang II и TGF-ß1 в моче у крыс, не получавших иАПФ, отражает выраженность склеротических изменений в почечной ткани. Раннее назначение иАПФ с целью блокады Ang II и ренопротекции снижает формирование фиброзной ткани в почках за счет снижения продукции фибробластами экстрацеллюлярного матрикса и профиброгенных факторов роста, но не влияет на уже сформировавшиеся очаги склероза.</p></abstract><trans-abstract xml:lang="en"><p>In the experimental simulations bacterial vesico-ureteral reflux of rats, the results of the morphological studies at individuals gave us the possibility to identify various non-typical structural-anatomic changes in the renal-ureteral complex at 1, 3 and 6 months and to clarify the definite morphological status of the structural components of the kidneys at the individuals. The severity of the morphofunctional changes in renal parenchyma is interconnected with the severity and the duration of the VUR and the inflammatory process with the development of tubulointerstitial fibrosis. High levels of Ang II and TGF-ß1 in the urine of rats receiving no inhibitors reflects the severity of sclerotic changes in the renal tissue. Early administration of inhibitors for the purpose of the blockade of Ang II and renoprotection, reduce the formation of fibrosis tissue in the kidneys by reducing the production of extracellular matrix by fibroblasts and profibrogenic growth factors, but do not eliminate already formed foci sclerosis.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>эксперимент</kwd><kwd>инфекция мочевых путей</kwd><kwd>крысы</kwd><kwd>пузырно-мочеточниковый рефлюкс</kwd><kwd>тубулоинтерстициальный фиброз</kwd></kwd-group><kwd-group xml:lang="en"><kwd>experiment</kwd><kwd>urinary tract infection</kwd><kwd>vesico-ureteral reflux</kwd><kwd>rats</kwd><kwd>tubulointerstitial fibrosis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Giovanni M, Kjell T, Hewitt I. Febrile Urinary Tract Infections in Children. New Engl J of Medicine 2011; 365:239-250</mixed-citation><mixed-citation xml:lang="en">Giovanni M, Kjell T, Hewitt I. Febrile Urinary Tract Infections in Children. New Engl J of Medicine 2011; 365:239-250</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Peters C, Rushton HG. Vesicoureteral reflux associated renal damage: congenital reflux nephropathy and acquired renal scarring. J Urol 2010;184(1):265-273</mixed-citation><mixed-citation xml:lang="en">Peters C, Rushton HG. Vesicoureteral reflux associated renal damage: congenital reflux nephropathy and acquired renal scarring. J Urol 2010;184(1):265-273</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Tej K. Mattoo. Vesicoureteral Reflux and Reflux Nephropathy. Adv Chronic Kidney Dis 2011; 18(5): 348-354</mixed-citation><mixed-citation xml:lang="en">Tej K. Mattoo. Vesicoureteral Reflux and Reflux Nephropathy. Adv Chronic Kidney Dis 2011; 18(5): 348-354</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Лакомова ДЮ, Стародубова АВ, Максимова АВ. Ранняя диагностика и прогнозирование развития нефросклероза у детей с пузырно-мочеточниковым рефлюксом. Bulletin of Medical Internet Conferences 2012: 2(1):27-28. [Lakomova DYU, Starodubova AV, Maksimova AV. Rannyaya diagnostika i prognozirovanie razvitiya nefroskleroza u detej s puzyrno-mochet-ochnikovym reflyuksom. Bulletin of Medical Internet Conferences 2012: 2(1):27-28]</mixed-citation><mixed-citation xml:lang="en">Лакомова ДЮ, Стародубова АВ, Максимова АВ. Ранняя диагностика и прогнозирование развития нефросклероза у детей с пузырно-мочеточниковым рефлюксом. Bulletin of Medical Internet Conferences 2012: 2(1):27-28. [Lakomova DYU, Starodubova AV, Maksimova AV. Rannyaya diagnostika i prognozirovanie razvitiya nefroskleroza u detej s puzyrno-mochet-ochnikovym reflyuksom. Bulletin of Medical Internet Conferences 2012: 2(1):27-28]</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Annual report. 2010. The EMMES Corporation, Rockville, MD</mixed-citation><mixed-citation xml:lang="en">North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Annual report. 2010. The EMMES Corporation, Rockville, MD</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Oh MM, Kim JW, Park MG et al. The impact of therapeutic delay time on acute scintigraphic lesion and ultimate scar formation in children with first febrile UTI. Eur J Pediatr 2012;171(3):565</mixed-citation><mixed-citation xml:lang="en">Oh MM, Kim JW, Park MG et al. The impact of therapeutic delay time on acute scintigraphic lesion and ultimate scar formation in children with first febrile UTI. Eur J Pediatr 2012;171(3):565</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Skoog SJ, Peters CA, Arant BS Jr et al. Pediatric Vesicoureteral Reflux Guidelines Panel Summary Report: Clinical Practice Guidelines for Screening Siblings of Children With Vesicoureteral Reflux and Neonates/Infants With Prenatal Hydronephrosis. J Urol 2010;184(3):1145-1151</mixed-citation><mixed-citation xml:lang="en">Skoog SJ, Peters CA, Arant BS Jr et al. Pediatric Vesicoureteral Reflux Guidelines Panel Summary Report: Clinical Practice Guidelines for Screening Siblings of Children With Vesicoureteral Reflux and Neonates/Infants With Prenatal Hydronephrosis. J Urol 2010;184(3):1145-1151</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Heather J. Lambert Primary, Nonsyndromic Vesicoureteric Reflux and Nephropathy in Sibling Pairs: A United Kingdom Cohort for a DNA Bank. CJASN, 2011; 6 (4 ) 760-766</mixed-citation><mixed-citation xml:lang="en">Heather J. Lambert Primary, Nonsyndromic Vesicoureteric Reflux and Nephropathy in Sibling Pairs: A United Kingdom Cohort for a DNA Bank. CJASN, 2011; 6 (4 ) 760-766</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Massanyi EZ, Preece J, Gupta A, et al. Utility of screening ultrasound after first febrile UTI among patients with clinically significant vesicoureteral reflux. Urology 2013;82(4):905</mixed-citation><mixed-citation xml:lang="en">Massanyi EZ, Preece J, Gupta A, et al. Utility of screening ultrasound after first febrile UTI among patients with clinically significant vesicoureteral reflux. Urology 2013;82(4):905</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Salo J, Ikäheimo R, Tapiainen T et al. Childhood urinary tract infections as a cause of chronic kidney disease. Pediatrics 2011;128(5):840</mixed-citation><mixed-citation xml:lang="en">Salo J, Ikäheimo R, Tapiainen T et al. Childhood urinary tract infections as a cause of chronic kidney disease. Pediatrics 2011;128(5):840</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Shaikh N, Ewing AL, Bhatnagar S et al. Risk of renal scarring in children with a first urinary tract infection: a systematic review. Pediatrics 2010;126:1084-1091</mixed-citation><mixed-citation xml:lang="en">Shaikh N, Ewing AL, Bhatnagar S et al. Risk of renal scarring in children with a first urinary tract infection: a systematic review. Pediatrics 2010;126:1084-1091</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Paltiel HJ, Mulkern RV, Perez-Atayde A et al. Effect of chronic, low-pressure, sterile vesicoureteral reflux on renal growth and function in a porcine model: a radiologic and pathologic study. Radiology 2000; 217(2):507-515</mixed-citation><mixed-citation xml:lang="en">Paltiel HJ, Mulkern RV, Perez-Atayde A et al. Effect of chronic, low-pressure, sterile vesicoureteral reflux on renal growth and function in a porcine model: a radiologic and pathologic study. Radiology 2000; 217(2):507-515</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Baek M, Paick SH, Jeong SJ et al. Urodynamic and histological changes in a sterile rabbit vesicoureteral reflux model. J Korean Med Sci 2010;25(9):1352-1358</mixed-citation><mixed-citation xml:lang="en">Baek M, Paick SH, Jeong SJ et al. Urodynamic and histological changes in a sterile rabbit vesicoureteral reflux model. J Korean Med Sci 2010;25(9):1352-1358</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Slotki IN, Asscher AW. Prevention of renal scarring in experimental pyelonephritis in the rat by early antibiotic therapy. Nephron 1982;30:262-268</mixed-citation><mixed-citation xml:lang="en">Slotki IN, Asscher AW. Prevention of renal scarring in experimental pyelonephritis in the rat by early antibiotic therapy. Nephron 1982;30:262-268</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Roberts JA, Kaack MB, Baskin G. Treatment of experimental pyelonephritis in the monkey. J Urol 1990;143(1):150-154</mixed-citation><mixed-citation xml:lang="en">Roberts JA, Kaack MB, Baskin G. Treatment of experimental pyelonephritis in the monkey. J Urol 1990;143(1):150-154</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Silva AC, Flynn JT. The rennin-angiotensin-aldosteron system in 2011: role in hypertension and chronic kidney disease. Pediatr Nephrol 2012. DOI 10.10007/s0046-011-2002</mixed-citation><mixed-citation xml:lang="en">Silva AC, Flynn JT. The rennin-angiotensin-aldosteron system in 2011: role in hypertension and chronic kidney disease. Pediatr Nephrol 2012. DOI 10.10007/s0046-011-2002</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Hussein A, Askar E, Elsaeid M, Schaefer F. Functional polymorphisms in transforming growth factor-beta-1 (TGFbeta-1) and vascular endothelial growth factor (VEGF) genes modify risk of renal parenchymal scarring following childhood urinary tract infection. Nephrol Dial Transplant 2010;25:779-785</mixed-citation><mixed-citation xml:lang="en">Hussein A, Askar E, Elsaeid M, Schaefer F. Functional polymorphisms in transforming growth factor-beta-1 (TGFbeta-1) and vascular endothelial growth factor (VEGF) genes modify risk of renal parenchymal scarring following childhood urinary tract infection. Nephrol Dial Transplant 2010;25:779-785</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Hussein A, Askar E, Elsaeid M, Schaefer F. Functional polymorphisms in transforming growth factor-beta-1 (TGFbeta-1) and vascular endothelial growth factor (VEGF) genes modify risk of renal parenchymal scarring following childhood urinary tract infection. Nephrol Dial Transplant 2010;25(3):779-785</mixed-citation><mixed-citation xml:lang="en">Hussein A, Askar E, Elsaeid M, Schaefer F. Functional polymorphisms in transforming growth factor-beta-1 (TGFbeta-1) and vascular endothelial growth factor (VEGF) genes modify risk of renal parenchymal scarring following childhood urinary tract infection. Nephrol Dial Transplant 2010;25(3):779-785</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Меркоданова ЮА, Утц ИА. Цитокиновый профиль мочи при различных этиопатогенетических вариантах хронического пиелонефрита у детей. Саратовск науч-мед журн 2011; 7(4): 901-904 [Merkodanova ΥA, Utts IА. Titokinovii profil mohi pri razlichnih ehtiopatogeneticheskih variantah khronicheskogo pielonefrita u detei. Saratovskii nauchno-meditsinskii jurnal 2011; 7(4): 901-904]</mixed-citation><mixed-citation xml:lang="en">Меркоданова ЮА, Утц ИА. Цитокиновый профиль мочи при различных этиопатогенетических вариантах хронического пиелонефрита у детей. Саратовск науч-мед журн 2011; 7(4): 901-904 [Merkodanova ΥA, Utts IА. Titokinovii profil mohi pri razlichnih ehtiopatogeneticheskih variantah khronicheskogo pielonefrita u detei. Saratovskii nauchno-meditsinskii jurnal 2011; 7(4): 901-904]</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Ibragim Gokce, Harica Alpay, Nese Biykli et al. Urinary levels of interleikin-6 and interleikin-8 in patients with vesicoureteral reflux and renal parenchymal scar. Peadiatr Nephrol 2010; 25:905-912</mixed-citation><mixed-citation xml:lang="en">Ibragim Gokce, Harica Alpay, Nese Biykli et al. Urinary levels of interleikin-6 and interleikin-8 in patients with vesicoureteral reflux and renal parenchymal scar. Peadiatr Nephrol 2010; 25:905-912</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Morales MG, Vazquez Y Acuna MJ, Rivera JC, Simon F. Angiotensin II-induced pro-fibrotic effects require p38MAPK activity and transforming growth factor beta 1 expression in skeletal muscle cells. Int J Biochem Cell Biol 2012 Nov;44(11):1993-2002</mixed-citation><mixed-citation xml:lang="en">Morales MG, Vazquez Y Acuna MJ, Rivera JC, Simon F. Angiotensin II-induced pro-fibrotic effects require p38MAPK activity and transforming growth factor beta 1 expression in skeletal muscle cells. Int J Biochem Cell Biol 2012 Nov;44(11):1993-2002</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Rizvi S, Raza ST, Mahdi F. Association of genetic variants with diabetic nephropathy. World J Diabetes 2014: 15;5(6):809-186</mixed-citation><mixed-citation xml:lang="en">Rizvi S, Raza ST, Mahdi F. Association of genetic variants with diabetic nephropathy. World J Diabetes 2014: 15;5(6):809-186</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Huo P, Zhang D, Guan X et al. Association between genetic polymorphisms of ACE &amp; eNOS and diabetic nephropathy. Mol Biol Rep 2015;42(1):27-33</mixed-citation><mixed-citation xml:lang="en">Huo P, Zhang D, Guan X et al. Association between genetic polymorphisms of ACE &amp; eNOS and diabetic nephropathy. Mol Biol Rep 2015;42(1):27-33</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Мачехина ЛЮ. Современные взгляды на патогенетические механизмы, течение, прогноз и методы лечения рефлюкс-нефропатии: Автореф. дис.. канд. мед. наук. М., 2010; 38 с. [Machehina LU. Sovremennie vzgliadi na patogeneticheskie mehanizmi, tehenie, prognoz i metodi lechenia refluks-nefropatii. Аvtor. diss. na sosk. uh. step. kand. med. nauk, Moskva, 2010, 38 s]</mixed-citation><mixed-citation xml:lang="en">Мачехина ЛЮ. Современные взгляды на патогенетические механизмы, течение, прогноз и методы лечения рефлюкс-нефропатии: Автореф. дис.. канд. мед. наук. М., 2010; 38 с. [Machehina LU. Sovremennie vzgliadi na patogeneticheskie mehanizmi, tehenie, prognoz i metodi lechenia refluks-nefropatii. Аvtor. diss. na sosk. uh. step. kand. med. nauk, Moskva, 2010, 38 s]</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Паунова СС, Ольхова ЕБ. Оценка эффективности ингибиторов АПФ у детей с пузырно-мочеточниковым рефлюксом методом допплеровского исследования ренального кровотока. Материалы 1 Всероссийского конгресса «Современные технологии в педиатрии и детской хирургии. М., 2002; 399-400. [Paunova SS, Olhova EB. Otenka effektivnosti ingibitorov APF u detei s puzyrno-mohetochnikovim refluksom metodom dopplerovskogo issledovania renalnogo krovotoka. Materiali 1 Vserossiiskogo kongressa «Sovremennie tehnologii v pediatrii i detskoi hirurgii. Moskva, 2002. S. 399-400]</mixed-citation><mixed-citation xml:lang="en">Паунова СС, Ольхова ЕБ. Оценка эффективности ингибиторов АПФ у детей с пузырно-мочеточниковым рефлюксом методом допплеровского исследования ренального кровотока. Материалы 1 Всероссийского конгресса «Современные технологии в педиатрии и детской хирургии. М., 2002; 399-400. [Paunova SS, Olhova EB. Otenka effektivnosti ingibitorov APF u detei s puzyrno-mohetochnikovim refluksom metodom dopplerovskogo issledovania renalnogo krovotoka. Materiali 1 Vserossiiskogo kongressa «Sovremennie tehnologii v pediatrii i detskoi hirurgii. Moskva, 2002. S. 399-400]</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Лопухин ЮМ. Экспериментальная хирургия. М.: Медицина, 1971, 224 с. - прототип [Lopukhin YM. Eksperimentalnaa hirurgia. M.: Meditsina, 1971, s.224 - prototip]</mixed-citation><mixed-citation xml:lang="en">Лопухин ЮМ. Экспериментальная хирургия. М.: Медицина, 1971, 224 с. - прототип [Lopukhin YM. Eksperimentalnaa hirurgia. M.: Meditsina, 1971, s.224 - prototip]</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Khalil A, Tullus K, Bakhiet M et al. Angiotensin II type I receptor antagonist (Losartan) down regulates transforming growth factor-β in experimental acute pyelonephritis. J Urol 2000;164:186-191</mixed-citation><mixed-citation xml:lang="en">Khalil A, Tullus K, Bakhiet M et al. Angiotensin II type I receptor antagonist (Losartan) down regulates transforming growth factor-β in experimental acute pyelonephritis. J Urol 2000;164:186-191</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Rodriguez-Iturbe B, Quiroz Y Shahrarami A et al. Myco-phenole mofetil ameliorates nephropathy in the obese Zucker rat. Kidney Int 2005:68:1041-1047</mixed-citation><mixed-citation xml:lang="en">Rodriguez-Iturbe B, Quiroz Y Shahrarami A et al. Myco-phenole mofetil ameliorates nephropathy in the obese Zucker rat. Kidney Int 2005:68:1041-1047</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Peter J. Margetts, Catherine Hoff, Limin Liu. Transforming growth factor β-induced peritoneal fibrosis is mouse strain dependent. Oxford Journals Medicine Nephrology Dialysis Transplantation 2012 :28(8): 2015-2027</mixed-citation><mixed-citation xml:lang="en">Peter J. Margetts, Catherine Hoff, Limin Liu. Transforming growth factor β-induced peritoneal fibrosis is mouse strain dependent. Oxford Journals Medicine Nephrology Dialysis Transplantation 2012 :28(8): 2015-2027</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Gawlowska-Marciniak A, Niedzielski JK. Evaluation of TGF-ß1, CCL5/RANTES and sFas/Apo-1 urine concentration in children with ureteropelvic junction obstruction. Arch Med Sci 2013; 9(5): 888-894</mixed-citation><mixed-citation xml:lang="en">Gawlowska-Marciniak A, Niedzielski JK. Evaluation of TGF-ß1, CCL5/RANTES and sFas/Apo-1 urine concentration in children with ureteropelvic junction obstruction. Arch Med Sci 2013; 9(5): 888-894</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Kagami S, Border WA, Miller DE et al. Angiotensin II stimulates extracellular matrix protein synthesis through induction of TGF-ß1 expression in rat glomerular mesangial cells. J Clin Invest 1994; 93:2431-2437</mixed-citation><mixed-citation xml:lang="en">Kagami S, Border WA, Miller DE et al. Angiotensin II stimulates extracellular matrix protein synthesis through induction of TGF-ß1 expression in rat glomerular mesangial cells. J Clin Invest 1994; 93:2431-2437</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Serlachius E, Sundelin B, Eklof A. Pyelonephritis provokes growth retardation and apoptosis in infant rat renal cortex. Kidney Int 1997;51:1855-1862</mixed-citation><mixed-citation xml:lang="en">Serlachius E, Sundelin B, Eklof A. Pyelonephritis provokes growth retardation and apoptosis in infant rat renal cortex. Kidney Int 1997;51:1855-1862</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Liang XL. Beyond Early Diagnosis: Prognostic Biomarkers for Monitoring Acute Kidney Injury: X.-L. Liang, W. Shi. Hong Kong J Nephrol 2010; 12(2):45-49</mixed-citation><mixed-citation xml:lang="en">Liang XL. Beyond Early Diagnosis: Prognostic Biomarkers for Monitoring Acute Kidney Injury: X.-L. Liang, W. Shi. Hong Kong J Nephrol 2010; 12(2):45-49</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Singal AK, Bajpai M, Dinda AK. Blockade of rennin-аngiotensin system blunts the fibrotic response in experimental acute pyelonephritis. J of Indian Assot of pediat Surgeons Year 2005;10 (1):20-24</mixed-citation><mixed-citation xml:lang="en">Singal AK, Bajpai M, Dinda AK. Blockade of rennin-аngiotensin system blunts the fibrotic response in experimental acute pyelonephritis. J of Indian Assot of pediat Surgeons Year 2005;10 (1):20-24</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
